Department of Otolaryngology, University of Iowa, Iowa City, IA, USA.
Clin Genet. 2010 Jun;77(6):563-71. doi: 10.1111/j.1399-0004.2009.01344.x. Epub 2010 Feb 4.
Myosin VIIA mutations have been associated with non-syndromic hearing loss (DFNB2; DFNA11) and Usher syndrome type 1B (USH1B). We report clinical and genetic analyses of a consanguineous Iranian family segregating autosomal recessive non-syndromic hearing loss (ARNSHL). The hearing impairment was mapped to the DFNB2 locus using Affymetrix 50K GeneChips; direct sequencing of the MYO7A gene was completed. The Iranian family (L-1419) was shown to segregate a novel homozygous missense mutation (c.1184G>A) that results in a p.R395H amino acid substitution in the motor domain of the myosin VIIA protein. As one affected family member had significantly less severe hearing loss, we used a candidate approach to search for a genetic modifier. This novel MYO7A mutation is the first reported to cause DFNB2 in the Iranian population and this DFNB2 family is the first to be associated with a potential modifier. The absence of vestibular and retinal defects, and less severe low frequency hearing loss, is consistent with the phenotype of a recently reported Pakistani DFNB2 family. Thus, we conclude this family has non-syndromic hearing loss (DFNB2) rather than USH1B, providing further evidence that these two diseases represent discrete disorders.
肌球蛋白 VIIA 突变与非综合征性听力损失(DFNB2;DFNA11)和 1B 型 Usher 综合征(USH1B)有关。我们报告了一个连锁常染色体隐性非综合征性听力损失(ARNSHL)的伊朗近亲家庭的临床和遗传分析。使用 Affymetrix 50K GeneChips 将听力损伤映射到 DFNB2 基因座;完成了 MYO7A 基因的直接测序。伊朗家庭(L-1419)显示出一种新型纯合错义突变(c.1184G>A)的遗传,该突变导致肌球蛋白 VIIA 蛋白的运动结构域中出现 p.R395H 氨基酸取代。由于一名受影响的家庭成员的听力损失明显较轻,我们使用候选方法寻找遗传修饰因子。这种新型 MYO7A 突变是首次在伊朗人群中报道导致 DFNB2 的突变,而这个 DFNB2 家族是第一个与潜在修饰因子相关的家族。前庭和视网膜缺陷缺失以及低频听力损失较轻,与最近报道的巴基斯坦 DFNB2 家族的表型一致。因此,我们得出结论,这个家族患有非综合征性听力损失(DFNB2)而不是 USH1B,这进一步证明了这两种疾病是不同的疾病。